- Filed
- May 14, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · May 14, 2024 | 1.86B sh |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $24.43M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $20.91M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $17.12M |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $18.79M |
| Stockholders Equity | Q1 2024 · Mar 31, 2023 | $18.35M |
| Stockholders Equity | Q1 2024 · Dec 31, 2022 | $17.37M |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $14.84M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $12.04M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $18.72M |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $14.9M |
| Current Assets | Q1 2024 · Mar 31, 2024 | $27.8M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $24.45M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $35.84M |
| Total Assets | Q1 2024 · Dec 31, 2023 | $33.69M |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $11.8K |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $252.43K |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 3.67B sh |
| Dividends Paid | Q1 2024 · Mar 31, 2023 | $160.56K |
| Capex | Q1 2024 · Mar 31, 2023 | $617.76K |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | −$398.65K |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.00 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.00 |
| Net Income | Q1 2024 · Mar 31, 2023 | $407.89K |
| Operating Income | Q1 2024 · Mar 31, 2023 | $392.37K |
| Revenue | Q1 2024 · Mar 31, 2023 | $13.57M |